RZLT

SEC filing RZLT: 6 of 8 upLIFT Patients Meet Primary Endpoint, 100% Discontinue IV Glucose

1h ago

SEC filing RZLT Announces Phase 3 sunRIZE Study Topline Results in Congenital HI, CGM Shows >50% Hypoglycemia Reduction, OLE Extends 6-24 Mo Benefit

28d ago

News Rezolute gains after positive FDA meeting over lead asset

69d ago

SEC filing RZLT Updates FDA Meeting on sunRIZE HI Program, Targets 2026 Path Forward

70d ago

News INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA

132d ago

News DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

135d ago

News Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating

138d ago

News ECGI Highlights Fintech Expansion Through RezyFi Acquisition and Tokenized Mortgage Platform in Shareholder Letter

153d ago

News Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating

153d ago

News UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

159d ago

News UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

159d ago

Scanner Unusual volume (z=113.8)

171d ago